Life ScienceCompany
Par Pharmaceutical Companies M&A Summary
Par Pharmaceutical Companies has acquired 2 companies of its own. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Par Pharmaceutical Companies’ largest acquisition to date was in 2014, when it acquired JHP Pharmaceuticals for $490M. Par Pharmaceutical Companies has acquired in 2 different US states. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
Par Pharmaceutical Companies Ownership
Who owns Par Pharmaceutical Companies?
Par Pharmaceutical Companies is owned by Endo International. It was acquired on May 18, 2015.
Was Par Pharmaceutical Companies formerly PE-backed?
Yes. Par Pharmaceutical Companies was formerly owned by 1 private investor.
Par Pharmaceutical Companies Business Overview
Where is Par Pharmaceutical Companies headquartered?
Par Pharmaceutical Companies is headquartered in Woodcliff Lake, New Jersey.
How many employees does Par Pharmaceutical Companies have?
Par Pharmaceutical Companies has 978 employees.
What sector is Par Pharmaceutical Companies in?
Par Pharmaceutical Companies is a life science company.
When was Par Pharmaceutical Companies founded?
Par Pharmaceutical Companies was founded in 1978.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
